MingMed Biotechnology Co., Ltd. announced that it has received nearly $50,000,000 in a round of funding on September 13, 2021. The transaction included participation from Efung Capital, Yingke Innovation Asset Management Co., Ltd., Fosun RZ Venture Management Co., Ltd., new investors Jifeng Ventures, Yifeng Capital, Oceanpine Capital Limited, Yatsen Holding Limited, returning investors Gaorong Capital, JCP Capital, Guangzhou Flower City Venture Capital Management Co., Ltd. and Zhuhai Huajin Capital Co., Ltd. The company has raised about $110 million in funding in the last six months.